Healthcare provider profile · identity verified

Sarbmeet Mann

Internal Medicine · SPRINGFIELD, OR · NPI 1902320039

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	684	186
Levothyroxine Sodium	Levothyroxine Sodium	614	123
Amlodipine Besylate	Amlodipine Besylate	474	127
Lisinopril	Lisinopril	408	109
Gabapentin	Gabapentin	298	76
Losartan Potassium	Losartan Potassium	294	82
Omeprazole	Omeprazole	259	71
Carvedilol	Carvedilol	240	62
Duloxetine Hcl	Duloxetine Hcl	235	59
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	216	34
Rosuvastatin Calcium	Rosuvastatin Calcium	200	50
Metoprolol Succinate	Metoprolol Succinate	199	60
Albuterol Sulfate Hfa	Albuterol Sulfate	195	63
Trazodone Hcl	Trazodone Hcl	194	53
Simvastatin	Simvastatin	184	41
Pravastatin Sodium	Pravastatin Sodium	183	60
Pantoprazole Sodium	Pantoprazole Sodium	170	45
Metformin Hcl Er	Metformin Hcl	169	46
Hydrochlorothiazide	Hydrochlorothiazide	166	52
Montelukast Sodium	Montelukast Sodium	166	46
Eliquis	Apixaban	151	36
Furosemide	Furosemide	149	37
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	138	44
Metformin Hcl	Metformin Hcl	136	40
Tamsulosin Hcl	Tamsulosin Hcl	135	40
Sertraline Hcl	Sertraline Hcl	133	33
Metoprolol Tartrate	Metoprolol Tartrate	129	32
Oxycodone Hcl	Oxycodone Hcl	129	21
Potassium Chloride	Potassium Chloride	129	38
Ezetimibe	Ezetimibe	114	36
Buspirone Hcl	Buspirone Hcl	113	25
Ozempic	Semaglutide	109	21
Tramadol Hcl	Tramadol Hcl	102	26
Tizanidine Hcl	Tizanidine Hcl	93	26
Warfarin Sodium	Warfarin Sodium	90	21
Quetiapine Fumarate	Quetiapine Fumarate	86	16
Allopurinol	Allopurinol	85	18
Escitalopram Oxalate	Escitalopram Oxalate	81	14
Fluticasone Propionate	Fluticasone Propionate	74	26
Jardiance	Empagliflozin	70	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	17
Famotidine	Famotidine	63	18
Glipizide Er	Glipizide	62	17
Alendronate Sodium	Alendronate Sodium	59	16
Mounjaro	Tirzepatide	59	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	suppressed
Lovastatin	Lovastatin	48	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	13
Spironolactone	Spironolactone	45	13
Venlafaxine Hcl Er	Venlafaxine Hcl	45	suppressed
Pregabalin	Pregabalin	43	14
Fluoxetine Hcl	Fluoxetine Hcl	42	13
Mirtazapine	Mirtazapine	41	14
Donepezil Hcl	Donepezil Hcl	38	11
Hydroxyzine Hcl	Hydroxyzine Hcl	38	11
Torsemide	Torsemide	37	suppressed
Trulicity	Dulaglutide	37	suppressed
Valsartan	Valsartan	37	suppressed
Aripiprazole	Aripiprazole	35	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Lorazepam	Lorazepam	34	12
Bupropion Xl	Bupropion Hcl	33	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Irbesartan	Irbesartan	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	31	11
Glipizide	Glipizide	31	14
Propranolol Hcl	Propranolol Hcl	31	12
Glimepiride	Glimepiride	30	suppressed
Finasteride	Finasteride	29	suppressed
Atenolol	Atenolol	28	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Ramelteon	Ramelteon	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Primidone	Primidone	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Ondansetron Odt	Ondansetron	26	14
Azelastine Hcl	Azelastine Hcl	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Topiramate	Topiramate	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Prednisone	Prednisone	20	12
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	19	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	19	19
Clonazepam	Clonazepam	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Digoxin	Digoxin	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Enskyce	Desogestrel-Ethinyl Estradiol	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Victoza 3-Pak	Liraglutide	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Testosterone	Testosterone	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Azathioprine	Azathioprine	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Modafinil	Modafinil	11	suppressed
Nadolol	Nadolol	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Trimethoprim	Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error